NAMSTEYA

Serial Number 98388302
730

Registration Progress

Application Filed
Feb 2, 2024
Under Examination
Nov 26, 2024
Approved for Publication
Oct 1, 2024
Published for Opposition
Oct 1, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 126 days

Trademark Image

NAMSTEYA

Basic Information

Serial Number
98388302
Filing Date
February 2, 2024
Published for Opposition
October 1, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 10, 2025
Application
Pending
Classes
005

Rights Holder

Emalex Biosciences, Inc.

03
Address
330 North Wabash, Suite #3500
Chicago, IL 60611

Ownership History

Emalex Biosciences, Inc.

Original Applicant
03
Chicago, IL

Emalex Biosciences, Inc.

Owner at Publication
03
Chicago, IL

Legal Representation

Attorney
Kristen Ruisi

USPTO Deadlines

Next Deadline
126 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

12 events
Date Code Type Description Documents
Apr 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 10, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 1, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 29, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 27, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 6, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders

Classification

International Classes
005